Bradley Foster & Sargent’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.5M Buy
132,665
+3,804
+3% +$550K 0.3% 72
2026
Q1
$15.2M Buy
128,861
+25,056
+24% +$3.29M 0.24% 89
2025
Q4
$12.4M Buy
103,805
+36,633
+55% +$4.17M 0.18% 99
2025
Q3
$6.73M Buy
67,172
+6,128
+10% +$730K 0.1% 138
2025
Q2
$7.87M Buy
+61,044
New +$7.43M 0.12% 127
2019
Q4
Sell
-52,460
Closed -$4.29M 364
2019
Q3
$4.29M Sell
52,460
-6,000
-10% -$488K 0.14% 121
2019
Q2
$5.51M Sell
58,460
-2,280
-4% -$195K 0.18% 97
2019
Q1
$5.15M Sell
60,740
-990
-2% -$74.3K 0.18% 101
2018
Q4
$3.89M Sell
61,730
-5,505
-8% -$355K 0.16% 114
2018
Q3
$4.6M Buy
67,235
+95
+0.1% +$6.66K 0.16% 115
2018
Q2
$4.18M Buy
67,140
+63,295
+1,646% +$3.87M 0.15% 123
2018
Q1
$201K Buy
+3,845
New +$211K 0.01% 342

Other funds holding NOVT

Bradley Foster & Sargent's NOVT Position: Q2 2026 in Review

Bradley Foster & Sargent increased its Novanta (NOVT) stake by 3% in Q2 2026, buying an estimated $550K and bringing the position to 132,665 shares worth $21.5M. The position accounts for 0.3% of the portfolio, ranked #72.

Bradley Foster & Sargent first reported a position in NOVT in Q1 2018 and has held it in 12 quarters since. 389 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

  • Bradley Foster & Sargent held 132,665 shares of Novanta worth $21.5M as of Q2 2026.
  • Bradley Foster & Sargent bought 3,804 Novanta shares in Q2 2026, an estimated $550K.
  • Novanta made up 0.3% of Bradley Foster & Sargent's portfolio in Q2 2026, its #72 holding.
  • Bradley Foster & Sargent first reported a position in Novanta in Q1 2018 and has held it in 12 quarters since.
  • 389 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.